You are here

Article info

Article menu
Rheumatoid arthritis
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers

Authors

  • Antti Palomäki Centre for Rheumatology and Clinical Immunology, and Department of Medicine, Turku University Hospital and University of Turku, Turku, Finland Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • FinnGen Rheumatology Clinical Expert Group
    Google scholar articles
  • Aarno Palotie Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Jukka Koskela Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Kari K Eklund Department of Rheumatology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland Orton Orthopaedic Hospital, Helsinki, Finland PubMed articlesGoogle scholar articles
  • Matti Pirinen Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland Department of Public Health, University of Helsinki, Helsinki, Finland Department of Mathematics and Statistics, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  • FinnGen
    Google scholar articles
  • Samuli Ripatti Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland Department of Public Health, University of Helsinki, Helsinki, Finland Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA PubMed articlesGoogle scholar articles
  • Tarja Laitinen Administration Center, Tampere University Hospital, Tampere, Finland PubMed articlesGoogle scholar articles
  • Nina Mars Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Nina Mars, Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki FI-00014, Finland; nina.mars{at}helsinki.fi
View Full Text

Citation

Palomäki A, FinnGen Rheumatology Clinical Expert Group, Palotie A, et al
Lifetime risk of rheumatoid arthritis-associated interstitial lung disease in MUC5B mutation carriers
Annals of the Rheumatic Diseases 2021;80:1530-1536.

Publication history

  • Received May 1, 2021
  • Accepted July 20, 2021
  • First published August 3, 2021.
Online issue publication 
February 28, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.